efalizumab
/EH1 F AH0 L AH0 Z UW1 M AE1 B/noun
- 1
(pharmacology) A recombinant humanized monoclonal antibody, formerly available to treat autoimmune diseases, especially psoriasis, by binding CD11a of lymphocyte function-associated antigen 1, and associated with fatal brain infections.
Translate “efalizumab” into another language
Choose a language below to open the translator with English selected as the source language.